Results of a multicenter double-blind phase I clinical trial of using of BCD-022 compared with Herceptin, used in combination with paclitaxel in patients with metastatic breast cancer
E. O. Ignatova
◽
M. A. Frolova
◽
O. N. Burdaeva
◽
M. N. Nechaeva
◽
A. P. Pechenyj
◽
...
K. Vallis
◽
R. Reilley
◽
D. Scollard
◽
J. Petronis
◽
C. Caldwell
◽
...
2015 ◽
Vol 4
(7)
◽
pp. 1051-1059
◽
Pavani Chalasani
◽
Marilyn Marron
◽
Denise Roe
◽
Kathryn Clarke
◽
Maria Iannone
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 1057-1057
◽
G. H. Jerusalem
◽
V. Dieras
◽
F. Cardoso
◽
J. Bergh
◽
A. Fasolo
◽
...
2009 ◽
Vol 7
(2)
◽
pp. 261
◽
F. Cardoso
◽
L. Gianni
◽
G. Jerusalem
◽
A. Fasolo
◽
J. Bergh
◽
...
R O'Regan
◽
F Andre
◽
M Campone
◽
M Naughton
◽
C Manlius
◽
...
1994 ◽
Vol 17
(1)
◽
pp. 45-49
◽
Charles L. Vogel
◽
Eduardo G. Gomez
2008 ◽
Vol 26
(15_suppl)
◽
pp. 1003-1003
◽
F. André
◽
M. Campone
◽
S. A. Hurvitz
◽
L. Vittori
◽
I. Pylvaenaeinen
◽
...
A Fasolo
◽
L Gianni
◽
A Rorive
◽
J Bergh
◽
V Dieras
◽
...
2019 ◽
Vol 25
(17)
◽
pp. 5212-5220
◽
Qiao Li
◽
Xiuwen Guan
◽
Shanshan Chen
◽
Zongbi Yi
◽
Bo Lan
◽
...
2009 ◽
Vol 7
(2)
◽
pp. 267
◽
S. Hurvitz
◽
R. O'Regan
◽
M. Campone
◽
C. Manlius
◽
L. Vittori
◽
...
Close
Export Citation Format
Close
Share Document
Close